Infectious disease expert: There are 'cascading negative impacts' of J&J vaccine pause

Dr. Amesh Adalja, a senior scholar at the Johns Hopkins Center for Health Security joins Kasie Hunt to discuss the consequences of halting the distribution of the Johnson & Johnson coronavirus vaccine. "The longer this pause continues in the United States, the harder it’s going to be to restart," he says.